SMTL ID : 6o8i.1

BTK In Complex With Inhibitor

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.42 Å

Oligo State

monomer

Ligands

1 x LTJ: 4-[(3S)-3-{[(2E)-but-2-enoyl]amino}piperidin-1-yl]-5-fluoro-2,3-dimethyl-1H-indole-7-carboxamide(Covalent)

LTJ.1: 17 residues within 4Å: Chain A: L.18, G.19, V.26, A.38, T.84, E.85, Y.86, M.87, A.88, G.90, C.91, L.93, N.94, R.135, L.138, V.156, L.157 10 PLIP interactions: 10 interactions with chain A Hydrophobic interactions: A:L.18, A:L.93, A:R.135, A:L.138 Hydrogen bonds: A:T.84, A:E.85, A:M.87, A:M.87, A:C.91 Water bridges: A:N.94

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Watterson, S.H. et al., Discovery of Branebrutinib (BMS-986195): A Strategy for Identifying a Highly Potent and Selective Covalent Inhibitor Providing Rapid in Vivo Inactivation of Bruton's Tyrosine Kinase (BTK). J. Med. Chem. (2019)

Release Date

2019-04-03

Peptides

Tyrosine-protein kinase BTK: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

Tyrosine-protein kinase BTK

Related Entries With Identical Sequence